Free Trial
NASDAQ:ACB

Aurora Cannabis (ACB) Stock Price, News & Analysis

Aurora Cannabis logo
$4.58 +0.11 (+2.35%)
Closing price 07/3/2025 03:57 PM Eastern
Extended Trading
$4.57 -0.01 (-0.22%)
As of 07/3/2025 04:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Aurora Cannabis Stock (NASDAQ:ACB)

Key Stats

Today's Range
$4.49
$4.61
50-Day Range
$3.91
$6.15
52-Week Range
$3.42
$7.20
Volume
708,073 shs
Average Volume
1.57 million shs
Market Capitalization
$257.16 million
P/E Ratio
41.59
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Aurora Cannabis Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
6th Percentile Overall Score

ACB MarketRank™: 

Aurora Cannabis scored higher than 6% of companies evaluated by MarketBeat, and ranked 920th out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Aurora Cannabis are expected to decrease by -4.35% in the coming year, from $0.46 to $0.44 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Aurora Cannabis is 41.59, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.65.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Aurora Cannabis is 41.59, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.66.

  • Price to Book Value per Share Ratio

    Aurora Cannabis has a P/B Ratio of 0.59. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Aurora Cannabis' valuation and earnings.
  • Percentage of Shares Shorted

    8.98% of the float of Aurora Cannabis has been sold short.
  • Short Interest Ratio / Days to Cover

    Aurora Cannabis has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in Aurora Cannabis has recently increased by 2.86%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Aurora Cannabis does not currently pay a dividend.

  • Dividend Growth

    Aurora Cannabis does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    8.98% of the float of Aurora Cannabis has been sold short.
  • Short Interest Ratio / Days to Cover

    Aurora Cannabis has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in Aurora Cannabis has recently increased by 2.86%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Aurora Cannabis has a news sentiment score of -0.17. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Aurora Cannabis this week, compared to 3 articles on an average week.
  • Search Interest

    16 people have searched for ACB on MarketBeat in the last 30 days. This is an increase of 78% compared to the previous 30 days.
  • MarketBeat Follows

    8 people have added Aurora Cannabis to their MarketBeat watchlist in the last 30 days. This is an increase of 14% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Aurora Cannabis insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.01% of the stock of Aurora Cannabis is held by insiders.

  • Percentage Held by Institutions

    47.63% of the stock of Aurora Cannabis is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Aurora Cannabis' insider trading history.
Receive ACB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aurora Cannabis and its competitors with MarketBeat's FREE daily newsletter.

ACB Stock News Headlines

Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
See More Headlines

ACB Stock Analysis - Frequently Asked Questions

Aurora Cannabis' stock was trading at $4.25 at the beginning of the year. Since then, ACB shares have increased by 7.6% and is now trading at $4.5750.

Aurora Cannabis Inc. (NASDAQ:ACB) announced its quarterly earnings data on Wednesday, June, 18th. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.11 by $0.04. The company earned $63.34 million during the quarter, compared to analyst estimates of $88.85 million. Aurora Cannabis had a trailing twelve-month return on equity of 0.13% and a net margin of 1.32%.
Read the conference call transcript
.

Shares of Aurora Cannabis reverse split on Tuesday, February 20th 2024.The 1-10 reverse split was announced on Tuesday, February 20th 2024. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Aurora Cannabis subsidiaries include these companies: Reliva LLC, Whistler Medical Marijuana Corporation, ICC Labs Inc., Anandia Labs Inc, MedReleaf Corp., CanniMed Therapeutics Inc., Larssen Ltd, and more.

Shares of ACB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aurora Cannabis investors own include Canopy Growth (CGC), Cronos Group (CRON), NVIDIA (NVDA), Meta Platforms (META), Humana (HUM), Marinus Pharmaceuticals (MRNS) and American Water Works (AWK).

Company Calendar

Last Earnings
6/18/2025
Today
7/05/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ACB
Previous Symbol
NYSE:ACB
Fax
N/A
Employees
1,130
Year Founded
2006

Profitability

Trailing P/E Ratio
41.59
Forward P/E Ratio
9.95
P/E Growth
N/A
Net Income
$1.63 million
Pretax Margin
5.94%

Debt

Sales & Book Value

Annual Sales
$246.72 million
Cash Flow
$0.62 per share
Price / Cash Flow
7.43
Book Value
$7.78 per share
Price / Book
0.59

Miscellaneous

Free Float
56,208,000
Market Cap
$257.16 million
Optionable
Optionable
Beta
1.75

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:ACB) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners